They will help you weigh the benefits against the potential risks and decide the best treatment plan for your diabetes
GLP-1 receptor agonism reduces appetite, slows gastric emptying, increases glucose-dependent insulin secretion, and suppresses glucagon
Potential Research Applications: Appetite control and satiety studies Blood glucose and insulin sensitivity research Obesity and metabolic syndrome models GLP-1 receptor pathway modulation investigations For laboratory research only
At the highest dose, participants lost an average of 17.5% of their body weight in just 24 weeks
As your body adapts to tirzepatide, your provider may increase the dose according to the standard tirzepatide dosing protocol
The standard approach follows a four-week ramp-up schedule: Week 1: One tablet (8mg naltrexone / 90mg bupropion) in the morning Week 2: One tablet in the morning, one in the evening Week 3: Two tablets in the morning, one in the evening Week 4 onward (maintenance): Two tablets in the morning, two in the evening The full contrave dose for weight loss at maintenance is four tablets per day two in the morning, two at night